pharmaceuticals

Global Custom Market Research Reports Provider Company

phone

Altimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 29
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Altimmune Inc (Altimmune), formerly Vaxin Inc is an immunotherapeutics company that develops vaccines and other biological products. The companys products include nasovax, an intranasally administered recombinant influenza vaccine; and heptcell, an immunotherapy for patients chronically infected with the hepatitis B virus. Its preclinical stage products include nasoshield, a vaccine for the prevention of anthrax disease following inhalation of pathogen spores; and oncosyn, an immunotherapeutic for treating solid cancer indications. Altimmunes products are used in the treatment of acute respiratory infections, chronic viral infections, and cancer. The company uses respirvec and densigen technologies for the development of vaccines. It has operations in London, UK; and Strasbourg, France. Altimmune is headquartered in Gaithersburg, Maryland, the US.

Altimmune Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altimmune Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Altimmune Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Altimmune Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Vaxin Raises USD16 Million in Venture Financing 10
Partnerships 11
Altimmune Enters into Contract Agreement with BARDA for NasoShield 11
Merger 12
Altimmune Merges with PharmAthene in Reverse Merger Transaction 12
Licensing Agreements 14
Valneva Enters into Licensing Agreement with Immune Targeting Systems for IC31 Adjuvant 14
Equity Offering 15
Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 15
Asset Transactions 17
WCCT Acquires Challenge Virus from Immune Targeting Systems 17
Acquisition 18
Vaxin Acquires Immune Targeting Systems 18
Altimmune Inc - Key Competitors 19
Altimmune Inc - Key Employees 20
Altimmune Inc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Mar 28, 2018: Altimmune Reports Financial Results for the Year Ended December 31, 2017 22
Nov 09, 2017: Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update 24
Aug 10, 2017: Altimmune Announces Second Quarter 2017 Financial Results and Provides Corporate Update 26
Corporate Communications 27
Jan 03, 2018: Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors 27
May 16, 2017: Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables

List of Tables
Altimmune Inc, Pharmaceuticals & Healthcare, Key Facts 2
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altimmune Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altimmune Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Altimmune Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vaxin Raises USD16 Million in Venture Financing 10
Altimmune Enters into Contract Agreement with BARDA for NasoShield 11
Altimmune Merges with PharmAthene in Reverse Merger Transaction 12
Valneva Enters into Licensing Agreement with Immune Targeting Systems for IC31 Adjuvant 14
Altimmune Raises USD14.7 Million in Private Placement of Series B Preferred Shares 15
WCCT Acquires Challenge Virus from Immune Targeting Systems 17
Vaxin Acquires Immune Targeting Systems 18
Altimmune Inc, Key Competitors 19
Altimmune Inc, Key Employees 20
Altimmune Inc, Subsidiaries 21

List Of Figures

List of Figures
Altimmune Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altimmune Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altimmune Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Altimmune Inc (Altimmune), formerly Vaxin Inc is an immunotherapeutics company that develops vaccines and other biological products. The companys products include nasovax, an intranasally administered recombinant influenza vaccine; and heptcell,

View Report

Altimmune UK Ltd (Altimmune), formerly Vaxin UK Limited, a subsidiary of Altimmune Inc, is a clinical stage immunotherapeutic biotechnology company that develops synthetic vaccines for mutating viruses. The company designs

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports